News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
Blog | ACC

The novel coronavirus (COVID-19, SARS-CoVo-2) has turned normal life across the world upside down, and that was no ...

Home April 01, 2020
Home
Videos | Structural Heart

A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line, Baylor Scott ...

Home April 01, 2020
Home
While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart Rhythm ...

Home April 01, 2020
Home
News | Coronavirus (COVID-19)

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a collaboration ...

Home March 31, 2020
Home
News

March 30, 2020 — Smokers who received smoking cessation counseling and used electronic cigarettes (e-cigarettes) ...

Home March 30, 2020
Home
News | Cardiovascular Surgery

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...

Home March 30, 2020
Home
News | Coronavirus (COVID-19)

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what is ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

Home March 30, 2020
Home
PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology

March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing ...

Home March 29, 2020
Home
News | Heart Failure

March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...

Home March 29, 2020
Home
Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020
Feature | Heart Valve Technology | Dave Fornell, Editor

March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve ...

Home March 29, 2020
Home
Subscribe Now